Enzyme used in antidepressants could help researchers develop prostate cancer treatments

Researchers studying a behavior-altering enzyme commonly used in depression medications uncover a link to cancer's growth and metastasis

2014-06-02

(Press-News.org) LOS ANGELES (May 30, 2014) – An international team of scientists including researchers at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute and the University of Southern California found that an enzyme commonly used as a target for antidepressants may also promote prostate cancer growth.

The study, published in the Journal of Clinical Investigation, found that suppressing the enzyme monoamine oxidase A, or MAOA, may reduce or even eliminate prostate tumor growth and metastasis in laboratory mice. The finding could open the door for physicians to use antidepressants to fight prostate cancer. Currently, drugs that inhibit MAOA enzymes are used to treat patients with mental illnesses like depression.

"When this enzyme is not suppressed, it produces a tumor-rich environment that fuels the growth and metastasis of prostate cancer cells," said Leland Chung, PhD, corresponding author of the paper and director of the Uro-Oncology Research Program at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute. "Suppressing this enzyme and combining it with current therapies may provide a better way to manage and cure men with metastatic prostate cancer."

MAOA regulates the amount of neurotransmitters in the central nervous system by deactivating and breaking them down. Like all enzymes in the brain, MAOA is needed in optimum quantities to work effectively on patients. Previous studies have shown that too much MAOA is linked with depression, while too little of the enzyme is linked with autism, aggression and anxiety.

"This is the first paper showing that MAOA plays an important role in prostate cancer progression and metastasis and may provide an unmet need in cancer treatment," said Jean C. Shih, University Professor at the USC School of Pharmacy, two-time National Institutes of Health MERIT awardee and co-corresponding author of the study.

INFORMATION: The research team also includes first author Boyang (Jason) Wu, PhD, a postdoctoral fellow in the Chung Laboratory at Cedars-Sinai, Haiyen E. Zhau, PhD, a research scientist at Cedars-Sinai and co-corresponding author of the study, and investigators from the Keck School of Medicine of USC and the Fourth Military Medical University in China.

This work was funded by the National Institutes of Health, Grant 5P01CA098912; the Department of Defense PCRP Grant W81XWH-12-1-0282; the USC-Taiwan Center for Translational Research; and the Daniel Tsai Family Fund.

Citation: Journal of Clinical Investigation. 2014 May: Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.

ELSE PRESS RELEASES FROM THIS DATE:

Virus rounds up enzymes, disarms plant

2014-06-02

University of Tokyo researchers have described how a plant-virus protein suppresses an important plant defense mechanism that remembers viral genetic information, providing a new target for developing the first-ever chemical against plant viruses that globally cause more than $60 billion of crop losses each year. Invading viruses carry genetic material that hijacks the host cell's machinery, fooling it into producing proteins and new viruses. All cells from fungi to plants and mammals employ RNA silencing, a cellular process essential for the regulation of gene expression ...

New Population Council research presented at 13th ESC Annual Congress

2014-06-02

LISBON, PORTUGAL (31 May 2014) – This week, the Population Council presented new research at the 13th Congress of the European Society of Contraception and Reproductive Health. Presentations included a pharmacokinetic analysis of the Council's investigational one-year contraceptive vaginal ring containing Nestorone® and ethinyl estradiol, and its investigational male contraceptive implant MENT®, as well as new approaches to "green contraception," including strategies to ensure that future contraceptive technologies are both effective and protect the environment. "The ...

Clinical trial shows drug combination may be effective in recurrent ovarian cancer

2014-06-02

VIDEO: Dr. Joyce Liu talks about her clinical trial showing drug combination may be effective in recurrent ovarian cancer. Click here for more information. CHICAGO –– Significant improvement with the use of a combination drug therapy for recurrent ovarian cancer was reported at the annual meeting of the American Society of Clinical Oncology (ASCO) meeting in Chicago today. This is the first ovarian cancer study to use a combination of drugs that could be taken orally. The ...

New data shows ProMark accurately predicts aggressive prostate cancer, pathology outcomes

2014-06-02

CAMBRIDGE, Massachusetts, June 2, 2014 – Today, for the first time, Metamark presents results from the clinical validation study that showed ProMark™, the first and only proteomic-based imaging biopsy test, achieved its primary endpoint by accurately differentiating between aggressive and non-aggressive forms of prostate cancer at early stages of disease. ProMark™ was shown to predict which patients have low-risk disease with a sensitivity of 90 percent or better, confidently identifying patients who are appropriate for active surveillance or need aggressive therapy. The ...

Study shows tale of 2 prognoses in pediatric brain tumor, pilocytic astrocytoma

2014-06-02

Pilocytic astrocytoma (PA) is a primarily pediatric brain tumor caused mainly by mutations in the BRAF gene. In fact, there are two specific mechanisms for activation of BRAF implicated in PA formation: by fusion of the gene with nearby gene KIAA1549 (K:B fusion) or by point mutations of the BRAF gene itself. Research presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 used a newly designed test for K:B fusion to show that point mutations lead to a more dangerous form of the disease than does K:B fusion. "Overall, the prognosis for Pilocytic ...

DREAM project crowdsources answer to cancer cell drug sensitivities

2014-06-02

A study published June 1 in the journal Nature Biotechnology describes the results of an open challenge to predict which breast cancer cell lines will respond to which drugs, based only on the sum of cells' genomic data. The winning entry, from the Helsinki Institute for Information Technology, was 78 percent accurate in identifying sensitive versus resistant cell lines, and was one of 44 algorithms submitted by groups from around the world. "The idea is simple – we have this question and anybody can participate in searching for the answer. The question is, do we have ...

A master of disguise: A new stick insect species from China

2014-06-02

Many representatives of the fauna possess unique masking abilities but stick insects are among the masters of disguise within the animal world. During a field trip in Guangxi, China Mr. Ho Wai-chun George from the Hong Kong Entomological Society discovers a new species from this enigmatic insect group, which he describes in a recent research paper published in the open access journal Deutsche Entomologische Zeitschrift. Like the name suggests the new stick insect Sinophasma damingshanensis is distinguished by peculiarly elongated body and green-brownish coloration, which ...

New species from the past

2014-06-02

A piece of Eocene Baltic Amber of about 45 million years age contains a well preserved extinct flat bug, which turned out to be a new species to science. This exciting discovery is one of the many secrets that deposits of Baltic amber have revealed in the last years and are yet to come in the future. The study describing the new species was published in the open access journal Deutsche Entomologische Zeitschrift. The new species Aradus macrosomus is a rather large representative of the genus, differing by its size and particular structures from its congeners. The name ...

Same face, many first impressions

2014-06-02

Slight variations in how an individual face is viewed can lead people to develop significantly different first impressions of that individual, according to research published in Psychological Science, a journal of the Association for Psychological Science. "Our findings suggest that impressions from still photos of individuals could be deeply misleading," says psychological scientist and study author Alexander Todorov of Princeton University. Previous research has shown that people form first impressions about someone's personality after viewing their face only briefly. ...

What finding out a child's sex before birth says about a mother

2014-06-02

COLUMBUS, Ohio – An expectant mother who chooses to find out her child's sex before birth may be giving subtle clues about her views on proper gender roles, new research suggests. The study found that women who choose not to learn their child's sex may be more open to new experiences, and combine egalitarian views about the roles of men and women in society with conscientiousness. On the other hand, expectant mothers who scored high on a test of parenting perfectionism were more likely than others to learn their baby's sex. "These results suggest women who choose ...

Enzyme used in antidepressants could help researchers develop prostate cancer treatments

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: